Across
- 1. day 8, day 60 and monthly after day 60
- 4. neither the PI or the patient will know if they are receiving the mRNA or placebo
- 7. includes assessment of skin, eyes, ears, throat, head, etc
- 8. must be signed before any blood draws or vaccination
- 9. must be this age or older to participate
- 10. ____ 2/3
- 13. medical history of COPD, CHF, asthma, etc
- 15. a PN must be left saying ____ if PI does not think any abnormalities will affect the subjects eligibility
- 17. ____ to follow up
- 18. can be same day as vaccination
- 19. the amount of minutes the patient must be sitting before taking vitals
Down
- 2. >= 38 degrees celsius
- 3. reported up to 7 days after injection
- 5. runny nose
- 6. study length
- 11. tattoos over the deltoid area
- 12. collected day 1 to day 28
- 14. virus the study is for
- 16. according to the assessment of intensity, these events cause some interference with the participant’s daily activities and require limited or no medical intervention.